chr7-130671775-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_052933.4(TSGA13):āc.544A>Gā(p.Asn182Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000239 in 1,592,450 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_052933.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TSGA13 | NM_052933.4 | c.544A>G | p.Asn182Asp | missense_variant | 7/8 | ENST00000356588.8 | |
TSGA13 | NM_001304968.2 | c.544A>G | p.Asn182Asp | missense_variant | 8/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TSGA13 | ENST00000356588.8 | c.544A>G | p.Asn182Asp | missense_variant | 7/8 | 1 | NM_052933.4 | P1 | |
TSGA13 | ENST00000456951.5 | c.544A>G | p.Asn182Asp | missense_variant | 8/9 | 2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152226Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000284 AC: 7AN: 246146Hom.: 0 AF XY: 0.0000225 AC XY: 3AN XY: 133372
GnomAD4 exome AF: 0.0000194 AC: 28AN: 1440106Hom.: 0 Cov.: 30 AF XY: 0.0000153 AC XY: 11AN XY: 716644
GnomAD4 genome AF: 0.0000656 AC: 10AN: 152344Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74510
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2022 | The c.544A>G (p.N182D) alteration is located in exon 7 (coding exon 6) of the TSGA13 gene. This alteration results from a A to G substitution at nucleotide position 544, causing the asparagine (N) at amino acid position 182 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at